In order to cope with the spread of the new coronavirus 2019-nCoV worldwide that has caused severe impacts, Leadgene Biomedical is going to provide free antibody-development technic to promote the development of epidemic prevention.

Leadgene Biomedical publicly solicits five cooperation plans either from industry or academia, which are expected to be executed in March. Leadgene Biomedical regards this assistance as a part of corporate social responsibility and values the role that biomedical companies play in global healthcare.


 COVID-19 Feature Products